Vascular Risk Factors in Patients with Different Subtypes of Ischemic Stroke May Affect Their Outcome after Intravenous tPA

Intravenous (IV) tissue-type plasminogen activator (tPA) is the only approved noninvasive therapy for acute ischemic stroke (AIS). However, after tPA treatment, the outcome of patients with different subtypes of stroke according to their vascular risk factors remains to be elucidated. We aim to expl...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Yi, Cao, Wenjie, Ren, Jinma, Nair, Deepak S., Parker, Sarah, Jahnel, Jan L., Swanson-Devlin, Teresa G., Beck, Judith M., Mathews, Maureen, McNeil, Clayton J., Upadhyaya, Manas, Gao, Yuan, Dong, Qiang, Wang, David Z.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4527733/
https://www.ncbi.nlm.nih.gov/pubmed/26247772
http://dx.doi.org/10.1371/journal.pone.0131487

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4527733/
https://www.ncbi.nlm.nih.gov/pubmed/26247772
http://dx.doi.org/10.1371/journal.pone.0131487

Ejemplares similares